Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Becton Dickinson and Company (BDX)

Becton Dickinson and Company (BDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 51,956,876
  • Shares Outstanding, K 284,742
  • Annual Sales, $ 21,840 M
  • Annual Income, $ 1,678 M
  • EBIT $ 2,675 M
  • EBITDA $ 5,137 M
  • 60-Month Beta 0.25
  • Price/Sales 2.38
  • Price/Cash Flow 7.91
  • Price/Book 2.06

Options Overview Details

View History
  • Implied Volatility 26.45% (-0.85%)
  • Historical Volatility 28.27%
  • IV Percentile 53%
  • IV Rank 39.82%
  • IV High 40.49% on 04/10/25
  • IV Low 17.15% on 02/24/25
  • Expected Move (DTE 28) 13.46 (7.26%)
  • Put/Call Vol Ratio 0.20
  • Today's Volume 1,018
  • Volume Avg (30-Day) 1,065
  • Put/Call OI Ratio 0.55
  • Today's Open Interest 18,051
  • Open Int (30-Day) 22,624
  • Expected Range 171.93 to 198.85

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 2.77
  • Number of Estimates 6
  • High Estimate 2.78
  • Low Estimate 2.76
  • Prior Year 3.35
  • Growth Rate Est. (year over year) -17.31%

Price Performance

See More
Period Period Low Period High Performance
1-Month
153.80 +20.54%
on 01/23/26
185.50 -0.06%
on 02/20/26
+25.49 (+15.94%)
since 01/20/26
3-Month
148.21 +25.09%
on 12/09/25
185.50 -0.06%
on 02/20/26
+36.35 (+24.39%)
since 11/20/25
52-Week
127.59 +45.31%
on 11/06/25
185.50 -0.06%
on 02/20/26
+6.20 (+3.46%)
since 02/20/25

Most Recent Stories

More News
Lanesha Minnix Named General Counsel for BD

FRANKLIN LAKES, N.J. , Feb. 19, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Lanesha Minnix has been named...

BDX : 185.39 (+1.60%)
5 Must-Read Analyst Questions From BD’s Q4 Earnings Call

5 Must-Read Analyst Questions From BD’s Q4 Earnings Call

BDX : 185.39 (+1.60%)
Are Wall Street Analysts Bullish on Becton, Dickinson and Company Stock?

Becton, Dickinson and Company has lagged behind the broader market over the past year, yet analysts remain somewhat optimistic about the stock’s prospects.

XLV : 156.82 (-0.28%)
$SPX : 6,909.51 (+0.69%)
BDX : 185.39 (+1.60%)
Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt Securities

FRANKLIN LAKES, N.J. , Feb. 10, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) (the " Company " or " BD "), a leading global medical technology company, today announced...

BDX : 185.39 (+1.60%)
BDX Q4 Deep Dive: Portfolio Reshaping and Product Investments Offset Tariff Headwinds

BDX Q4 Deep Dive: Portfolio Reshaping and Product Investments Offset Tariff Headwinds

BDX : 185.39 (+1.60%)
Stocks Settle Higher on Strength in Tech

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.47%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.77%. March E-mini S&P...

AMAT : 375.38 (+1.50%)
APP : 418.68 (+1.62%)
TGNA : 20.83 (-0.19%)
B : 47.96 (-1.22%)
AVGO : 332.65 (-0.40%)
HL : 24.02 (+5.40%)
CDE : 24.63 (+2.37%)
HIMS : 15.63 (-1.20%)
WAT : 333.33 (+1.42%)
$IUXX : 25,012.62 (+0.87%)
ASML : 1,469.59 (+0.73%)
ZNH26 : 112-300s (-0.03%)
Stocks Recover Early Losses as Tech Stocks Rebound

The S&P 500 Index ($SPX ) (SPY ) today is up +0.46%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.61%. March E-mini S&P futures (ESH26...

APO : 119.72 (+1.17%)
APP : 418.68 (+1.62%)
TGNA : 20.83 (-0.19%)
B : 47.96 (-1.22%)
AVGO : 332.65 (-0.40%)
HL : 24.02 (+5.40%)
CDE : 24.63 (+2.37%)
HIMS : 15.63 (-1.20%)
WAT : 333.33 (+1.42%)
$IUXX : 25,012.62 (+0.87%)
ASML : 1,469.59 (+0.73%)
ZNH26 : 112-300s (-0.03%)
Stocks Slip Ahead of this Week's US News on Jobs and Inflation

The S&P 500 Index ($SPX ) (SPY ) today is down -0.03%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.34%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.17%. March E-mini S&P futures...

APO : 119.72 (+1.17%)
TGNA : 20.83 (-0.19%)
HIMS : 15.63 (-1.20%)
TXN : 219.73 (+0.77%)
WAT : 333.33 (+1.42%)
$IUXX : 25,012.62 (+0.87%)
ZNH26 : 112-300s (-0.03%)
DT : 35.40 (-2.43%)
MNDY : 75.58 (-0.55%)
ESH26 : 6,923.25s (+0.67%)
STX : 411.11 (+0.52%)
BDX : 185.39 (+1.60%)
BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation

FRANKLIN LAKES, N.J. , Feb. 9, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) today announced the successful completion of the previously announced spin-off of BD's Biosciences...

BDX : 185.39 (+1.60%)
WAT : 333.33 (+1.42%)
BD (NYSE:BDX) Surprises With Q4 CY2025 Sales

BD (NYSE:BDX) Surprises With Q4 CY2025 Sales

BDX : 185.39 (+1.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational...

See More

Key Turning Points

3rd Resistance Point 190.64
2nd Resistance Point 188.07
1st Resistance Point 186.73
Last Price 185.39
1st Support Level 182.82
2nd Support Level 180.25
3rd Support Level 178.91

See More

52-Week High 185.50
Last Price 185.39
Fibonacci 61.8% 163.38
Fibonacci 50% 156.54
Fibonacci 38.2% 149.71
52-Week Low 127.59

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar